|
|
|
|
|
|
|
|
Advanced cancer
Purpose
Advanced breast, non-small cell lung, colorectal and ovarian cancers; as well as patients who are phase I trial candidates
Substantial progress has been made in the treatment of cancer
through the use of targeted therapies, but what works for one patient
might not work for another patient. Certain drugs are now being
developed that target specific molecules in the body that are believed
to be part of the disease.
Biomarkers are specific characteristics of the cancer
that may help provide prognostic information (i.e. how well patients
will be regardless of the treatments given) or help predict sensitivity
or resistance to a specific treatment.
The study will collect archival tumor samples (previously collected biopsy or surgical tumor samples) to provide biomarker data about a patient's cancer,
in order to help their physicians to identify which clinical trials of
molecularly targeted therapies may be most appropriate for the patient
in the future.
Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT)
This study is not yet open for participant recruitment.
Verified on January 2012 by University Health Network, Toronto
First Received on January 4, 2012.
Last Updated on January 5, 2012
History of Changes
Sponsor: | University Health Network, Toronto |
---|---|
Collaborator: | Princess Margaret Hospital, Canada |
Information provided by (Responsible Party): | University Health Network, Toronto |
ClinicalTrials.gov Identifier: | NCT01505400 |
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.